2010
DOI: 10.1007/s00436-010-1997-5
|View full text |Cite
|
Sign up to set email alerts
|

Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drug

Abstract: Albendazole is a benzimidazole drug which can be used to treat liver fluke (Fasciola hepatica) infections. Its mode of action is believed to be the inhibition of microtubule formation through binding to β-tubulin. However, F. hepatica expresses at least six different isotypes of β-tubulin, and this has confused, rather than clarified, understanding of the molecular mechanisms of benzimidazole drugs in this organism. Recombinant F. hepatica β-tubulin proteins were expressed in, and purified from, Escherichia co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(9 citation statements)
references
References 42 publications
0
8
0
1
Order By: Relevance
“…Since 2000, most previous studies have focused on the proteomic analysis of the excretory-secretory products of F. hepatica . , Findings were mainly the identification of proteases (such as cathepsin L proteases and leucyl aminopeptidase) and antioxidants (such as glutathione transferases, fatty acid binding proteins and thioredoxin peroxidase), important for the digestion of the host tissue and the parasite’s defense mechanism (detoxification of reactive oxygen elements), respectively. The proteolytic enzymes and antioxidants have been proposed as vaccine candidates (reviewed in refs , ), and others including β-tubulins in the tegument are important as drug (such as for benzimidazole drugs) targets. , Recent proteomic studies have characterized other F. hepatica proteins including a developmentally regulated heat shock protein and 14-3-3z protein …”
Section: Introductionmentioning
confidence: 99%
“…Since 2000, most previous studies have focused on the proteomic analysis of the excretory-secretory products of F. hepatica . , Findings were mainly the identification of proteases (such as cathepsin L proteases and leucyl aminopeptidase) and antioxidants (such as glutathione transferases, fatty acid binding proteins and thioredoxin peroxidase), important for the digestion of the host tissue and the parasite’s defense mechanism (detoxification of reactive oxygen elements), respectively. The proteolytic enzymes and antioxidants have been proposed as vaccine candidates (reviewed in refs , ), and others including β-tubulins in the tegument are important as drug (such as for benzimidazole drugs) targets. , Recent proteomic studies have characterized other F. hepatica proteins including a developmentally regulated heat shock protein and 14-3-3z protein …”
Section: Introductionmentioning
confidence: 99%
“…3 and Additional file 5 : Table S3). This is an interesting observation taking into account the putative role of tubulins as targets of ABZ, TCBZ and other benzimidazole-based drugs [ 70 , 71 ].
Fig.
…”
Section: Resultsmentioning
confidence: 99%
“…In terms of drug resistance, the isolated parasite in the present study was found to be susceptible to albendazole (an anthelmintic benzimidazole drug). This was extrapolated by the comparative analysis of the translated aminoacid sequences of a F. hepatica transcript (annotated with tubulin beta-2 of F. hepatica ; #CAP72050.1; E value = 0) with the drug susceptibility associated amino acid residues (N-165; F-167; E-198; F-200; R-241) of tubulin beta-2 of F. hepatica [ 29 ].…”
Section: Resultsmentioning
confidence: 99%